January 2, 2019 / 2:06 PM / 19 days ago

CORRECTED-BRIEF-Banner Gets FDA Tentative Approval For Multiple Sclerosis Treatment Bafiertam

(Corrects source to Banner Life Sciences from Biogen)

Jan 2 (Reuters) - BANNER LIFE SCIENCES LLC:

* BANNER RECEIVES FDA TENTATIVE APPROVAL FOR BAFIERTAM FOR THE TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS

* BANNER LIFE SCIENCES LLC SAYS FULL APPROVAL EXPECTED NO LATER THAN JUNE 20, 2020 Source text: (reut.rs/2CJFbU1)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below